Swiss National Bank - ANTARES PHARMA INC ownership

ANTARES PHARMA INC's ticker is ATRS and the CUSIP is 036642106. A total of 79 filers reported holding ANTARES PHARMA INC in Q3 2014. The put-call ratio across all filers is 37.78 and the average weighting 0.1%.

Quarter-by-quarter ownership
Swiss National Bank ownership history of ANTARES PHARMA INC
ValueSharesWeighting
Q1 2022$1,566,000
+23.8%
382,000
+7.8%
0.00%0.0%
Q4 2021$1,265,000
-1.9%
354,3000.0%0.00%0.0%
Q3 2021$1,290,000
-15.2%
354,300
+1.5%
0.00%0.0%
Q2 2021$1,522,000
+2.4%
349,000
-3.5%
0.00%0.0%
Q1 2021$1,487,000
+4.6%
361,800
+1.5%
0.00%0.0%
Q4 2020$1,422,000
+47.7%
356,5000.0%0.00%0.0%
Q3 2020$963,000
+1.2%
356,500
+3.0%
0.00%0.0%
Q2 2020$952,000
+34.1%
346,100
+15.1%
0.00%0.0%
Q1 2020$710,000
-49.1%
300,700
+1.4%
0.00%0.0%
Q4 2019$1,394,000
+43.9%
296,500
+2.3%
0.00%0.0%
Q3 2019$969,000
+5.8%
289,800
+4.1%
0.00%0.0%
Q2 2019$916,000
+17.0%
278,500
+7.8%
0.00%0.0%
Q1 2019$783,000
+15.0%
258,400
+3.2%
0.00%0.0%
Q4 2018$681,000
+103.9%
250,500
+27.6%
0.00%0.0%
Q3 2015$334,000
-3.5%
196,300
+18.0%
0.00%0.0%
Q2 2015$346,000
-11.7%
166,400
+14.9%
0.00%0.0%
Q1 2015$392,000
+5.4%
144,8000.0%0.00%0.0%
Q4 2014$372,000
+48.2%
144,800
+5.5%
0.00%0.0%
Q3 2014$251,000
-31.6%
137,3000.0%0.00%0.0%
Q2 2014$367,000
-23.7%
137,3000.0%0.00%
-50.0%
Q1 2014$481,000
-1.6%
137,300
+25.8%
0.00%0.0%
Q4 2013$489,000
+10.4%
109,1000.0%0.00%0.0%
Q3 2013$443,000
-10.7%
109,100
-8.5%
0.00%0.0%
Q2 2013$496,000119,3000.00%
Other shareholders
ANTARES PHARMA INC shareholders Q3 2014
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 3,130,192$12,834,0005.32%
Velan Capital Investment Management LP 1,346,971$5,523,0005.12%
FIRST WILSHIRE SECURITIES MANAGEMENT INC 2,799,953$11,480,0004.03%
Sargent Investment Group, LLC 3,663,275$15,019,0003.78%
PERKINS CAPITAL MANAGEMENT INC 481,483$1,974,0001.62%
Rubric Capital Management LP 10,900,000$44,690,0001.62%
ORACLE INVESTMENT MANAGEMENT INC 1,720,000$7,052,0001.39%
Long Focus Capital Management, LLC 540,000$2,214,0000.28%
OBERWEIS ASSET MANAGEMENT INC/ 344,200$1,411,0000.28%
FIRETHORN WEALTH PARTNERS, LLC 84,069$345,0000.26%
View complete list of ANTARES PHARMA INC shareholders